novavax nuvaxovid - Search News

Order byBest matchMost fresh

FDA Approves Novavax COVID-19

Third COVID Vaccine Gets Approved for Adults 65 and Over

According to federal data, older adults represent 94 percent of all COVID-19 deaths. And while hospitalizations are lower now than they were during peak periods, the hospitalization rate for adults 65...

· 7h · on MSN

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

· 50m

US approves Novavax COVID jab after delay, adds restrictions

· 1d

FDA Approves Novavax COVID-19 Shot but With Unusual Restrictions

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions.

· 6h

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

· 1d

FDA approves Novavax COVID vaccine with new conditions

Stocktwits on MSN7h

Novavax Stock Rips Nearly 20% Pre-Market After FDA Approves Its COVID-19 Vaccine Nuvaxovid

Pharmaceutical giant Novavax on Monday announced that the U.S. Food and Drug Administration (FDA) approved its COVID-19 vaccine, Nuvaxovid. Novavax’s shares traded nearly 20% in pre-market trading at the time of writing.

Schaeffer's Investment Research6h

Novavax Stock Soars on FDA Approval for COVID Vaccine

In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with 57,000 calls and 13,000 puts exchanged so far. The weekly 5/23 9-strike call is the most active, with new positions opening there.